Evidence map›Paper›PMID 12715165›Full record

ArticleEuropean journal of pediatrics2003

The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection.

Claudia Rolinck-Werninghaus, Klaus Magdorf, Klaus Stark, Konstantin Lyashchenko, Maria Laura Gennaro, Roberto Colangeli, T Mark Doherty, Peter Andersen, Georg Plum, Udo Herz and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Claudia Rolinck-WerninghausDepartment of Paediatric Pneumology and Immunology, Charité, Humboldt University, Augustenburger Platz 1, 13353 , Berlin, Germany. claudia.rolinck-werninghaus@charite.de.
Klaus MagdorfDepartment of Paediatric Pneumology and Immunology, Charité, Humboldt University, Augustenburger Platz 1, 13353 , Berlin, Germany.
Klaus StarkRobert-Koch-Institute, Berlin, Germany.
Konstantin LyashchenkoChembio Diagnostic Systems, Medford, USA.
Maria Laura GennaroPublic Health Research Institute, Newark, USA.
Roberto ColangeliMontefiore Medical Centre, New York, USA.
T Mark DohertyStatens Seruminstitut, Copenhagen, Denmark.
Peter AndersenStatens Seruminstitut, Copenhagen, Denmark.
Georg PlumInstitute of Medical Microbiology and Hygiene, Cologne, Germany.
Udo HerzDepartment of Clinical Chemistry and Molecular Diagnostics, University of Marburg, Marburg, Germany.
Harald RenzDepartment of Clinical Chemistry and Molecular Diagnostics, University of Marburg, Marburg, Germany.
Ulrich WahnDepartment of Paediatric Pneumology and Immunology, Charité, Humboldt University, Augustenburger Platz 1, 13353 , Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, BacterialBacterial ProteinsChemokines, CXCIntercellular Signaling Peptides and ProteinsAdolescentChemokine CXCL9ChildChild, PreschoolHumansInfantMycobacterium avium-intracellulare InfectionTuberculosisAntigens, BacterialBacterial ProteinsChemokine CXCL9Chemokines, CXCCXCL9 protein, humanESAT-6 protein, Mycobacterium tuberculosisIntercellular Signaling Peptides and ProteinsMPT63 antigen, Mycobacterium tuberculosis

Identifiers

PMID12715165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.